Table 1.

Patient characteristics

Age, mean (s.d.), years	55 (14)
Female, %	67
RF+, %	66
anti-CCP+, %	67
TJC28, 0−28, median (IQR)	2 (0–7)
SJC28, 0−28, median (IQR)	1 (0–4)
Patient global, 0−100, median (IQR)	33 (12–50)
CRP, median (IQR), mg/dl	0.8 (0.3–1.7)
MBDA score, mean (s.d.)	43 (15)
DAS28–CRP, median (IQR)	3.3 (2.3–4.3)
Erosion score, median (IQR)	14 (6–31)
JSN score, median (IQR)	8 (2–19)
SHS, median (IQR)	23 (11–47)

N = 163 patients. All data are for first visits. For RF status n = 161; for anti-CCP status n = 162. IQR: interquartile range; JSN: joint space narrowing; MBDA: multi-biomarker disease activity; N/A: not applicable; SHS: Sharp–van der Heijde score; SJC28: swollen joint count for 28 joints; TJC28: tender joint count for 28 joints.